You can take a look at Pharmesis, another pharmceutical company that starts to show some promising signs in making and distributing drugs for treating liver and gall bladder illnesses...
It has cash of 3.9c per share. Price is like Starpharm a few months ago at 4 - 4.5c now.
2011 2012 2013 all reported loss...will it go into SGX-watchlist next year. Plus market capitalisation of $8.8m(200m shares * $0.044) less than sgx requirement $40m
philipng wrote: 2011 2012 2013 all reported loss...will it go into SGX-watchlist next year. Plus market capitalisation of $8.8m(200m shares * $0.044) less than sgx requirement $40m
Hi Philipng,
Thank u for your opinion. Yes, profit has been negative for last 2 yrs and first 2 qtrs. And, did you observe that free cash flow started to become positive for last 2 qtrs?
Profit may soon turn positive. Go and take a look at its 2012 Annual Report nad you should see something interesting from the mgt's message